Primary Periodic Paralysis is a rare genetic condition impacting 3,000-4,000 Americans characterized by repeated episodes of extreme muscle weakness or temporary paralysis, often triggered by ...

and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome.